Free Trial
LON:BVXP

Bioventix (BVXP) Share Price, News & Analysis

Bioventix logo
GBX 2,950 -50.00 (-1.67%)
As of 02/21/2025 11:39 AM Eastern

About Bioventix Stock (LON:BVXP)

Key Stats

Today's Range
2,900
3,040
50-Day Range
2,820
3,480.21
52-Week Range
2,700
5,100
Volume
7,332 shs
Average Volume
4,917 shs
Market Capitalization
£154.47 million
P/E Ratio
19.08
Dividend Yield
5.36%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.

Receive BVXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioventix and its competitors with MarketBeat's FREE daily newsletter.

BVXP Stock News Headlines

Elon Takes Aim at Social Security
Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social Security, finding what he says is widespread fraud across the agency.
See More Headlines

BVXP Stock Analysis - Frequently Asked Questions

Bioventix's stock was trading at GBX 3,240 at the beginning of 2025. Since then, BVXP stock has decreased by 9.0% and is now trading at GBX 2,950.
View the best growth stocks for 2025 here
.

Bioventix PLC (LON:BVXP) released its earnings results on Monday, October, 28th. The biotechnology company reported $155.12 earnings per share for the quarter. Bioventix had a trailing twelve-month return on equity of 69.09% and a net margin of 59.51%.

Shares of BVXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bioventix investors own include Lancashire (LRE), Avast (AVST), Victrex (VCT), boohoo group (BOO), Tullow Oil (TLW), Airbnb (ABNB) and Avon Protection (AVON).

Company Calendar

Last Earnings
10/28/2024
Today
2/22/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
Cannabis
CIK
N/A
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

Net Income
£8.12 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£13.65 million
Cash Flow
GBX 95.51 per share
Book Value
GBX 229.94 per share

Miscellaneous

Free Float
N/A
Market Cap
£154.47 million
Optionable
Not Optionable
Beta
0.35
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (LON:BVXP) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners